Showing results (1-10 of 804) with videos related to
Sort By:
Pageof 81
Schweizerische Medizinische Wochenschrift|March 4, 1995
[Is the assessment of prothrombin fragment F1+2 for monitoring of heparin therapy in patients with deep vein thrombosis useful?]W Korte, C Corbetta, L SchmidDeutsche Medizinische Wochenschrift (1946)|March 19, 1993
[Kasabach-Merritt syndrome. Intraoperative heparin therapy with follow-up combination therapy of heparin and ticlopidine for the control of intravascular coagulation]W Korte, G Blatter, J P Ziegler, et al.Clinical Chemistry and Laboratory Medicine|June 25, 1998
Preoperative values of molecular coagulation markers identify patients at low risk for intraoperative haemostatic disorders and excessive blood lossW Korte, B Truttmann, C Heim, et al.Klinische Padiatrie|July 1, 1994
Increased thrombin generation during fibrinogen and platelet recovery as an explanation for hypercoagulability in children with L-asparaginase therapy for ALL or NHL: a preliminary reportW Korte, A Feldges, C Baumgartner, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 12, 1997
Plasma hypercoagulability in haemodialysis patients: impact of dialysis and anticoagulationP M Ambühl, R P Wüthrich, W Korte, et al.Neuropediatrics|December 1, 1994
Childhood stroke at three years of age with transient protein C deficiency, familial antiphospholipid antibodies and F. XII deficiency--a family studyW Korte, H Otremba, S Lutz, et al.Annals of Hematology|February 1, 1994
Coincidence of familial platelet glycoprotein Ib/IX deficiency (Bernard-Soulier syndrome), idiopathic autoantibody against platelet glycoprotein Ib/IX, familial appearance of antiphospholipid antibodies, and familial factor XII deficiencyW Korte, C Baumgartner, A Feldges, et al.Hamostaseologie|September 6, 2006
[Fibrin monomer and factor XIII: a new concept for unexplained intraoperative coagulopathy]W KorteClinical Chemistry and Laboratory Medicine|November 9, 2000
Changes of the coagulation and fibrinolysis system in malignancy: their possible impact on future diagnostic and therapeutic proceduresW KortePageof 81